Comparison of healthcare resource use and treatment among prostate cancer patients with and without DNA damage repair gene mutations.

被引：0
|
作者：
Liu, Jinan
Near, Aimee
Chiarappa, Joseph A.
Wada, Keiko
Tse, Jenny
Burudpakdee, Chakkarin
Behl, Ajay S.
Antonarakis, Emmanuel S.
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] IQVIA, Durham, NC USA
[3] IQVIA, Fairfax, VA USA
[4] IQVIA, Cambridge, MA USA
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e17059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17059
引用
收藏
页数：1
相关论文
共 50 条
  • [31] GENE MUTATIONS AMONG PROSTATE CANCER PATIENTS WITH A SMOKING HISTORY
    El-shafie, Ahmed
    Feibus, Allison H.
    Al-Toubat, Mohammed
    Lelani, Navid
    Jazayeri, SeyedBehzad
    Koul, Kashyap
    Marino, Robert A.
    Bandyk, Mark
    Costa, Joseph
    Balaji, K. C.
    JOURNAL OF UROLOGY, 2023, 209 : E220 - E221
  • [32] Concordance of DNA damage repair (DDR) gene mutations in paired primary and metastatic prostate cancer (PC) samples.
    Schweizer, Michael Thomas
    Sivakumar, Smruthy
    Tukachinsky, Hanna
    Coleman, Ilsa
    De Sarkar, Navonil
    Yu, Evan Y.
    Konnick, Eric Quentin
    Nelson, Peter
    Pritchard, Colin C.
    Montgomery, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] The impact of DNA damage repair gene mutations on therapeutic response among Chinese patients diagnosed with advanced biliary tract cancer.
    Gou, Hongfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Comparison of medical resource use and associated cost before and after docetaxel treatment among prostate cancer patients.
    Mehra, M.
    Wu, Y.
    Dhawan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Comparison of molecular signatures in small cell lung cancer with or without homologous recombination associated gene mutations.
    Fu, Lili
    Li, Feifei
    Ren, Dandan
    Mao, Beibei
    Chen, Huan
    Hao, Pei
    He, Ji
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
    Karzai, Fatima
    VanderWeele, David
    Madan, Ravi A.
    Owens, Helen
    Cordes, Lisa M.
    Hankin, Amy
    Couvillon, Anna
    Nichols, Erin
    Bilusic, Marijo
    Beshiri, Michael L.
    Kelly, Kathleen
    Krishnasamy, Venkatesh
    Lee, Sunmin
    Lee, Min-Jung
    Yuno, Akira
    Trepel, Jane B.
    Merino, Maria J.
    Dittamore, Ryan
    Marte, Jennifer
    Donahue, Renee N.
    Schlom, Jeffrey
    Killian, Keith J.
    Meltzer, Paul S.
    Steinberg, Seth M.
    Gulley, James L.
    Lee, Jung-Min
    Dahut, William L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [37] Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer
    Mailyan, O. A.
    Kalpinskiy, A. S.
    Reshetov, I., V
    Nyushko, K. M.
    Alekseev, B. Ya
    Kokin, S. P.
    Stakanov, V. A.
    Golovashchenko, M. P.
    ONKOUROLOGIYA, 2021, 17 (01): : 82 - 88
  • [38] Re: Inherited DNA-repair Gene Mutations in Men with Metastatic Prostate Cancer
    McLeod, David G.
    Srivastava, Shiv
    EUROPEAN UROLOGY, 2017, 71 (04) : 692 - 692
  • [39] DNA repair gene panel mutations in young onset prostate cancer cases in the.
    Eeles, Ros A.
    Leongamornlert, Daniel
    Saunders, Ed
    Wakerell, Sarah
    Whitmore, Ian
    Dadaev, Tokhir
    Borrella, Clara Cieza
    Govindasami, Koveela
    Brook, Mark
    Lophatananon, Artitaya
    Muir, Kenneth
    Conti, David V.
    Kote-Jarai, Zsofia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] Re: Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
    Lazzeri, Massimo
    Lughezzani, Giovanni
    EUROPEAN UROLOGY, 2016, 70 (04) : 703 - 704
12345